Patients with metabolic syndrome, insulin resistance, or fatty liver disease alongside elevated triglycerides tend to show stronger responses to GLP-1 treatment because the medication is addressing multiple contributing mechanisms simultaneously
Reduction in inflammation and oxidative stress Excess visceral fat is associated with inflammation and oxidative stress, which contribute to serious health conditions like cardiovascular disease and liver disease
Venous blood samples for PK measurements were collected on day 1 (predose and at 0.5, 1, 2, 4, 6, 8, 12, and 16 h postdose) and days 2, 8, and 15 (predose)
To implement effective site rotation: Divide each injection area (abdomen, thigh, or arm) into sections Keep a simple record or mental note of which section was used for each weekly injection Move at least 23 cm away from the previous injection point Avoid returning to the same specific spot for several weeks Patients should inspect injection sites regularly for any signs of persistent redness, unusual lumps, or other changes
Some people experience temporary increased anxiety before symptoms improve
Same dose, same injection schedule, same routine